Loading...

Home
Stock
XWEL

XWEL Overview

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

Loading chart...

High

1.175

Open

1.020

VWAP

1.12

Vol

189.94K

Mkt Cap

9.27M

Low

1.020

Amount

213.05K

EV/EBITDA(TTM)

--

Total Shares

7.93M

EV

18.89M

EV/OCF(TTM)

--

P/S(TTM)

0.20

XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.

Show More

Events Timeline

(ET)

2026-04-01

16:40:00

XWELL CEO Emphasizes Brand Relevance and Market Expansion

2026-02-03 (ET)

2026-02-03

08:30:00

Xwell Partners with PieQ for Biosecurity Forecasting Platform

2026-01-08 (ET)

2026-01-08

08:30:00

XWELL Expands Global Biosecurity Strategy, Appoints Former CDC Advisor as Senior Advisor

2025-12-18 (ET)

2025-12-18

08:20:00

XWELL Opens New Location in New York's Pennsylvania Station

2025-11-05 (ET)

2025-11-05

08:20:18

Xwell and Ostrichpillow Introduce Collaborative Eye Mask

2025-10-30 (ET)

2025-10-30

08:18:43

Xwell partners with Priority Pass for global expansion

2025-09-12 (ET)

2025-09-12

08:05:33

Xwell Unveils New Bloomingdale Wellness Center Opening

2025-08-11 (ET)

2025-08-11

08:08:30

Xwell regains compliance with Nasdaq min bid price requirement

News

seekingalpha

04-06seekingalpha

Trump Family-Linked Investment Backs XWell's AI Screening Rollout

Investment Scale: An investment vehicle linked to the Trump family, through Dominari Securities, has agreed to purchase approximately $31 million in convertible shares of XWell (XWEL), aiming to roll out AI-driven infectious disease screening at U.S. airports for the 2026 football World Cup, indicating strong confidence in the health tech sector.
Partnership Development: XWell has partnered with AI predictive analytics startup PieQ to deploy a 'next generation intelligence layer' designed to manage anticipated surges in U.S.-bound travel during major international events, thereby enhancing its competitive position in the market.
Market Reaction: Despite XWell (XWEL) trading about 3% lower in pre-market hours on Monday, the stock surged over 200% at the end of February following the announcement of a private placement with American Ventures, reflecting a positive market response to the scale of the funding relative to its sub-$10 million market capitalization at that time.
Brand Strategy: XWell operates several brands, including XpresSpa, providing wellness services and medical screenings at airports, and with the upcoming World Cup, it is expected to significantly enhance its influence in the airport health services market.

seekingalpha

04-01seekingalpha

XWELL Reports FY 2025 Financial Results with $29.2M Revenue

Revenue Performance: XWELL reported a revenue of $29.2 million for FY 2025, indicating a continued presence in the market despite a decline compared to the previous year.
Cost of Sales: The cost of sales for FY 2025 was approximately $21.7 million, down from $25.0 million in the prior year, suggesting progress in cost management efforts.
Operating Expenses: Operating expenses for FY 2025 totaled approximately $23.2 million, a decrease from $25.6 million in the previous year, reflecting effective spending management by the company.
Net Loss: The net loss attributable to XWELL for FY 2025 was approximately $17.0 million, slightly higher than the $16.9 million reported in the prior year, indicating ongoing challenges in achieving profitability.

Benzinga

XWELL Shares Surge 221% Following $31.3 Million Private Placement Announcement

Significant Financing: XWELL has entered into a securities purchase agreement with American Ventures to raise approximately $31.3 million through the issuance of Series H Convertible Preferred Stock, which is expected to significantly enhance the company's capital structure and liquidity.
Stock Price Surge: XWELL shares surged 221.43% on Wednesday, closing at $1.22, reflecting strong market optimism regarding the financing, which may attract more investor interest.
Clear Use of Proceeds: The company plans to utilize the raised funds to repurchase $5.95 million of certain notes and redeem its Series G preferred stock, with a total cash outlay of $9 million, which will help reduce financial costs and optimize its capital structure.
Transaction Completion Imminent: The private placement is anticipated to close on or around Thursday, further boosting market confidence in XWELL's future growth potential and potentially laying a solid foundation for the company's subsequent development.

stocktwits

02-25stocktwits

XWELL Completes $31.3 Million Private Placement

Private Placement Details: XWELL signed a securities purchase agreement with American Ventures to sell 31,333 shares of Series H Preferred Stock at $1,000 each, with the transaction expected to close on February 26, 2026, and proceeds earmarked for repurchasing $6 million in notes and redeeming certain preferred shares.
Stock Performance Recovery: XWEL shares surged above $1 for the first time since October 28, 2025, indicating a recovery after receiving a Nasdaq minimum bid price deficiency notice, as the company aims to maintain its stock price to avoid delisting risks.
Market Sentiment Shift: Retail sentiment on Stocktwits shifted from 'bearish' to 'extremely bullish', with expectations for the stock to rise to $2, reflecting increased investor confidence in the company's future performance, as the stock has gained nearly 220% year-to-date.
Clear Use of Funds: The funds from this transaction will be used to repurchase warrants covering 8.8 million common shares for $9 million, while the remaining proceeds will support general business expenses and working capital, demonstrating the company's focus on financial health.

Benzinga

U.S. Stocks Rise as TJX Reports Strong Earnings Beat

Market Performance: U.S. stocks broadly rose on Wednesday, with the Nasdaq Composite gaining over 250 points, indicating improved market sentiment, particularly as technology shares increased by 1.6%, reflecting heightened investor confidence in the tech sector.
TJX Earnings Report: TJX Companies reported fourth-quarter earnings of $1.43 per share, surpassing analyst expectations of $1.39, with sales reaching $17.743 billion, also exceeding the consensus estimate of $17.370 billion, showcasing the company's robust performance in retail.
Future Outlook: Despite TJX's FY2027 GAAP EPS guidance of $4.93 to $5.02 falling short of the market estimate of $5.17, the strong quarterly results may still attract investor interest, reflecting the company's resilience in an uncertain market environment.
Economic Data: The volume of mortgage applications in the U.S. increased by 0.4% in the third week of February, although this was lower than the previous week's 2.8% gain, indicating a gradual recovery in the housing market that could positively impact future economic growth.

Benzinga

U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 200 Points

Strong Dow Performance: The Dow Jones index gained over 200 points on Wednesday, rising 0.41% to close at 49,375.99, indicating positive market sentiment and increased investor confidence.
NASDAQ and S&P 500 Rise: The NASDAQ surged 0.77% to 23,040.20, while the S&P 500 rose 0.55% to 6,928.15, reflecting strong performances in technology and other major sectors.
Lowe's Earnings Beat Expectations: Lowe's reported Q4 earnings of $1.98 per share, exceeding analyst expectations of $1.94, with sales of $20.584 billion also surpassing the consensus estimate of $20.334 billion, although the company issued weaker future earnings guidance.
Energy Stocks Decline: Energy stocks fell by 0.3% on Wednesday, contrasting with a 0.8% rise in information technology shares, indicating a divergence in market performance that could influence investor asset allocation strategies.

Valuation Metrics

The current forward P/E ratio for XWELL Inc (XWEL.O) is 10.79, compared to its 5-year average forward P/E of -2.08. For a more detailed relative valuation and DCF analysis to assess XWELL Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-2.08

Current PE

10.79

Overvalued PE

2.51

Undervalued PE

-6.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-2.26

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

1.57

Undervalued EV/EBITDA

-6.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.96

Current PS

0.00

Overvalued PS

2.04

Undervalued PS

-0.12

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

news about stocks that are below 10 dollar

Intellectia · 100 candidates

Region: USPrice: $1.00 - $10.00Relative Vol: >= 2List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000News Driver: Positive, Negative

Ticker

Name

Market Cap$

XWELL Inc

6.98M

Larimar Therapeutics Inc

494.39M

VS Media Holdings Ltd

5.06M

Evolent Health Inc

350.52M

Navitas Semiconductor Corp

2.27B

Sharplink Inc

1.46B

low float high volume

Intellectia · 49 candidates

Region: USVolume: >= 500,000Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEFloating Shares: <= 20,000,000

Ticker

Name

Market Cap$

FAT Brands Inc

5.25M

Aprea Therapeutics Inc

5.57M

FAT Brands Inc

27.81M

cbdMD Inc

10.92M

Lixiang Education Holding Co Ltd

6.50M

Kaixin Holdings

29.77M

low float, high relative volume

Intellectia · 245 candidates

Relative Vol: >= 2Shares Outstanding: <= 50,000,000

Ticker

Name

Market Cap$

Global Interactive Technologies Inc

6.25M

PAVmed Inc

11.92M

Namib Minerals

121.31M

Smart Logistics Global Ltd

75.44M

Freight Technologies Inc

2.66M

Lisata Therapeutics Inc

35.55M

What Low Fload Stocks are surging Now

Intellectia · 24 candidates

Price Change Pct: >= $10.00Relative Vol: >= 2Shares Outstanding: <= 20,000,000

Ticker

Name

Market Cap$

Namib Minerals

121.31M

Global Interactive Technologies Inc

6.25M

Lisata Therapeutics Inc

35.55M

Moolec Science SA

4.71M

Boxlight Corp

1.73M

Pineapple Financial Inc

1.90M

increase the range for $0.12-$1.20

Intellectia · 13 candidates

Price: $0.12 - $1.20Volume: >= 3,000,000Relative Vol: >= 1.50List Exchange: XNAS

Ticker

Name

Market Cap$

Humacyte Inc

189.14M

Lucid Diagnostics Inc

148.14M

Oncolytics Biotech Inc

125.90M

Electra Battery Materials Corporation

97.40M

Cue Biopharma Inc

34.28M

Surgepays Inc

25.72M

i want you to find penny stocks $0.12-$.80

Intellectia · 9 candidates

Price: $0.12 - $0.80Volume: >= 3,000,000List Exchange: XNASIs Optionable: False

Ticker

Name

Market Cap$

Incannex Healthcare Inc

123.43M

Plus Therapeutics Inc

52.05M

MOBIX LABS, INC.

22.07M

IO Biotech Inc

14.94M

Jet.AI Inc

5.42M

American Rebel Holdings Inc

3.47M

Intellectia · 14 candidates

Market Cap: <= 2.00BPrice: <= $5.00Volume: >= 1,000,000Price Change Pct: >= $2.00Relative Vol: >= 1.10Rsi 14: <= 50Shares Outstanding: <= 50,000,000

Ticker

Name

Market Cap$

Empery Digital Inc

168.58M

Cassava Sciences Inc

104.83M

TryHard Holdings Ltd

38.04M

Borealis Foods Inc

25.33M

Cosmos Health Inc

19.42M

Safe & Green Holdings Corp

9.27M

penny stocks that will be bullish tomorrow

Intellectia · 9 candidates

Price: <= $5.00Relative Vol: >= 1.20Rsi 14: <= 40Moving Average Relationship: PriceCrossAboveMA5, PriceAboveMA20

Ticker

Name

Market Cap$

BRC Inc

247.13M

Zenvia Inc

47.05M

Borealis Foods Inc

25.33M

FAT Brands Inc

20.09M

Founder Group Ltd

2.79M

Freight Technologies Inc

2.66M

best under .5 stock to jump tomorrow

Intellectia · 8 candidates

Price: <= $0.50Relative Vol: >= 0.800Moving Average Relationship: PriceAboveMA5Week Price Change Pct: >= $-15.00

Ticker

Name

Market Cap$

Impact Biomedical Inc

52.31M

Plus Therapeutics Inc

52.05M

Cue Biopharma Inc

34.28M

Garden Stage Ltd

31.74M

Klotho Neurosciences Inc

24.27M

Captivision Inc

16.16M

Whales Holding XWEL

Trading Trends

Insider

Hedge Fund

Congress Trading

People Also Watch

Frequently Asked Questions

What is XWELL Inc (XWEL) stock price today?

The current price of XWEL is 1.17 USD — it has increased 12.5

What is XWELL Inc (XWEL)'s business?

XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.

What is the price predicton of XWEL Stock?

Wall Street analysts forecast XWEL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XWEL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is XWELL Inc (XWEL)'s revenue for the last quarter?

XWELL Inc revenue for the last quarter amounts to 7.15M USD, decreased -4.19

What is XWELL Inc (XWEL)'s earnings per share (EPS) for the last quarter?

XWELL Inc. EPS for the last quarter amounts to -3.18 USD, increased 120.83

How many employees does XWELL Inc (XWEL). have?

XWELL Inc (XWEL) has 175 emplpoyees as of April 19 2026.

What is XWELL Inc (XWEL) market cap?

Today XWEL has the market capitalization of 9.27M USD.